what's next in melanoma research on drug resistance?
Published 7 years ago • 65 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
1:05
addressing drug resistance and unresponsiveness in melanoma
-
10:42
what is new in melanoma?
-
2:13
cell cycle-dependent resistance or sensitivity to drugs and the importance of mitf genes in melanoma
-
1:11
chemotherapy for melanoma - why is it not effective and what is its future?
-
1:29
why dynamic heterogeneity is important for designing drugs in melanoma
-
2:38
what does skin cancer look like?
-
31:14
early detection of melanoma
-
19:25
melanoma review for the absite - questions and answers
-
1:30
planned 2024 studies in anti-pd-1 resistance
-
2:03
exploring adaptive drug resistance in melanoma
-
4:07
understanding resistance to combined braf and mek inhibiton in melanoma and the significance of cdk4
-
1:45
mechanisms of resistance to checkpoint inhibitors in melanoma
-
0:56
treating patients with melanoma who progressed on anti-pd-l1 with lenvatinib and pembrolizumab
-
1:30
blocking c-met and braf pathways in melanoma to overcome resistance in mouse models
-
2:28
future directions for research in non-melanoma skin cancer
-
1:39
advancements in use of combination drugs in clinical trials: nivolumab, pembrolizumab, and more
-
1:43
future directions in melanoma
-
4:06
cancer treatment: major milestones & what's next in the 2020s
-
3:44
neoadjuvant approaches in melanoma
-
1:01
what can be expected from novel comnination therapy trials in the future for melanoma
-
1:24
the next steps and clinical implications for wnt signalling for the treatment of melanoma
-
1:09
predicting resistance to targeted therapies in melanoma